{"transactions":[{"id":4627056,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":40823,"kind":"person","name":"Cox Russell J.","position":1,"cik":"0001512984","reported_name":"Cox Russell J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-25T20:43:41.000Z","date":"2026-09-23","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The entire number of shares subject to this option becomes fully vested and exercisable on the first anniversary of the grant date, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date."}],"balance_after":10000,"derivative":{"exercise_price":10.99,"expiration_date":"2036-09-22","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001628280-26-063601","document":"wk-form4_1790369018.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000162828026063601/wk-form4_1790369018.xml","form_type":"4"}},{"id":747563,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":40823,"kind":"person","name":"Cox Russell J.","position":1,"cik":"0001512984","reported_name":"Cox Russell J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-05T20:29:32.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":115000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award made pursuant to Non-Employee Director Compensation Program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date."}],"balance_after":115000,"derivative":{"exercise_price":0.178,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":115000},"source":{"system":"sec-edgar","filing":"0001512984-26-000001","document":"wk-form4_1780691368.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512984/000151298426000001/wk-form4_1780691368.xml","form_type":"4"}},{"id":1100878,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":40823,"kind":"person","name":"Cox Russell J.","position":1,"cik":"0001512984","reported_name":"Cox Russell J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-26T20:38:29.000Z","date":"2025-06-25","kind":"grant","planned":false,"acquired":true,"shares":115000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award made pursuant to Non-Employee Director Compensation Program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date."}],"balance_after":115000,"derivative":{"exercise_price":1.36,"expiration_date":"2035-06-24","underlying":"Common Stock","underlying_shares":115000},"source":{"system":"sec-edgar","filing":"0001728117-25-000057","document":"wk-form4_1750970302.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512984/000172811725000057/wk-form4_1750970302.xml","form_type":"4"}},{"id":1488111,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":40823,"kind":"person","name":"Cox Russell J.","position":1,"cik":"0001512984","reported_name":"Cox Russell J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option (Right to Buy)","published_at":"2024-06-07T01:58:08.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":115000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award made pursuant to Non-Employee Director Compensation Program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date."}],"balance_after":115000,"derivative":{"exercise_price":0.6,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":115000},"source":{"system":"sec-edgar","filing":"0001728117-24-000065","document":"wk-form4_1717725481.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512984/000172811724000065/wk-form4_1717725481.xml","form_type":"4"}},{"id":1840866,"issuer":{"id":2649,"kind":"organization","name":"Spyre Therapeutics, Inc.","symbol":"SYRE"},"owners":[{"id":40823,"kind":"person","name":"Cox Russell J.","position":1,"cik":"0001512984","reported_name":"Cox Russell J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-30T20:33:37.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":1950000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This option award is contingent upon receiving stockholder approval of the amendment and/or restatement of the 2016 Equity Incentive Plan to increase the number of shares available for issuance thereunder."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable in 12 equal monthly installments beginning on July 22, 2023, or on the date of the next annual meeting of stockholders, if earlier, subject to the continuing service of the Reporting Person on each vesting date."}],"balance_after":1950000,"derivative":{"exercise_price":0.3,"expiration_date":"2033-06-22","underlying":"Common Stock","underlying_shares":1950000},"source":{"system":"sec-edgar","filing":"0001209191-23-040335","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512984/000120919123040335/doc4.xml","form_type":"4"}},{"id":1860139,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":40823,"kind":"person","name":"Cox Russell J.","position":1,"cik":"0001512984","reported_name":"Cox Russell J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-09T20:15:35.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award made pursuant to Non-Employee Director Compensation Program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date."}],"balance_after":35000,"derivative":{"exercise_price":1.26,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001728117-23-000083","document":"wf-form4_168634170109729.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512984/000172811723000083/wf-form4_168634170109729.xml","form_type":"4"}},{"id":2206813,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":40823,"kind":"person","name":"Cox Russell J.","position":1,"cik":"0001512984","reported_name":"Cox Russell J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-15T21:06:51.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award made pursuant to Non-Employee Director Compensation Program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer'sstockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":7.02,"expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001728117-22-000073","document":"wf-form4_165791919498991.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512984/000172811722000073/wf-form4_165791919498991.xml","form_type":"4"}},{"id":2237351,"issuer":{"id":2649,"kind":"organization","name":"Spyre Therapeutics, Inc.","symbol":"SYRE"},"owners":[{"id":40823,"kind":"person","name":"Cox Russell J.","position":1,"cik":"0001512984","reported_name":"Cox Russell J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2022-06-10T01:13:38.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":43000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 12 equal monthly installments beginning on July 7, 2022, or on the date of the next annual meeting of stockholders, if earlier, subject to the continuing service of the Reporting Person on each vesting date."}],"balance_after":43000,"derivative":{"exercise_price":0.73,"expiration_date":"2032-06-06","underlying":"Common Stock","underlying_shares":43000},"source":{"system":"sec-edgar","filing":"0001209191-22-035684","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512984/000120919122035684/doc4.xml","form_type":"4"}},{"id":2673459,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":40823,"kind":"person","name":"Cox Russell J.","position":1,"cik":"0001512984","reported_name":"Cox Russell J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-10T23:49:33.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":23500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date."}],"balance_after":23500,"derivative":{"exercise_price":8.97,"expiration_date":"2031-06-08","underlying":"Common Stock","underlying_shares":23500},"source":{"system":"sec-edgar","filing":"0001728117-21-000058","document":"wf-form4_162336895818140.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512984/000172811721000058/wf-form4_162336895818140.xml","form_type":"4"}},{"id":2675136,"issuer":{"id":2649,"kind":"organization","name":"Spyre Therapeutics, Inc.","symbol":"SYRE"},"owners":[{"id":40823,"kind":"person","name":"Cox Russell J.","position":1,"cik":"0001512984","reported_name":"Cox Russell J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2021-06-09T21:23:00.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 12 equal monthly installments beginning on July 8, 2021, or on the date of the next annual meeting of stockholders, if earlier, subject to the continuing service of the Reporting Person on each vesting date."}],"balance_after":40000,"derivative":{"exercise_price":6.8,"expiration_date":"2031-06-07","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-21-039224","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512984/000120919121039224/doc4.xml","form_type":"4"}},{"id":3105119,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":40823,"kind":"person","name":"Cox Russell J.","position":1,"cik":"0001512984","reported_name":"Cox Russell J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-18T20:57:19.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":23500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date."}],"balance_after":23500,"derivative":{"exercise_price":12.1,"expiration_date":"2030-06-16","underlying":"Common Stock","underlying_shares":23500},"source":{"system":"sec-edgar","filing":"0001209191-20-037640","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512984/000120919120037640/doc4.xml","form_type":"4"}},{"id":3114386,"issuer":{"id":2649,"kind":"organization","name":"Spyre Therapeutics, Inc.","symbol":"SYRE"},"owners":[{"id":40823,"kind":"person","name":"Cox Russell J.","position":1,"cik":"0001512984","reported_name":"Cox Russell J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2020-06-10T20:23:41.000Z","date":"2020-06-08","kind":"grant","acquired":true,"shares":28100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 12 equal monthly installments beginning on July 8, 2020 until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date."}],"balance_after":28100,"derivative":{"exercise_price":8.89,"expiration_date":"2030-06-07","underlying":"Common Stock","underlying_shares":28100},"source":{"system":"sec-edgar","filing":"0001209191-20-035510","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512984/000120919120035510/doc4.xml","form_type":"4"}},{"id":3493798,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":40823,"kind":"person","name":"Cox Russell J.","position":1,"cik":"0001512984","reported_name":"Cox Russell J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-11T22:35:22.000Z","date":"2019-06-10","kind":"grant","acquired":true,"shares":23500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the\ngrant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board\nof directors of the Issuer through such vesting date."}],"balance_after":23500,"derivative":{"exercise_price":19.54,"expiration_date":"2029-06-09","underlying":"Common Stock","underlying_shares":23500},"source":{"system":"sec-edgar","filing":"0001209191-19-036216","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512984/000120919119036216/doc4.xml","form_type":"4"}},{"id":3496775,"issuer":{"id":2649,"kind":"organization","name":"Spyre Therapeutics, Inc.","symbol":"SYRE"},"owners":[{"id":40823,"kind":"person","name":"Cox Russell J.","position":1,"cik":"0001512984","reported_name":"Cox Russell J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2019-06-07T20:49:13.000Z","date":"2019-06-07","kind":"grant","acquired":true,"shares":12400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 12 equal monthly installments beginning on July 7, 2019 until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date."}],"balance_after":12400,"derivative":{"exercise_price":6.33,"expiration_date":"2029-06-06","underlying":"Common Stock","underlying_shares":12400},"source":{"system":"sec-edgar","filing":"0001567619-19-013070","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512984/000156761919013070/doc1.xml","form_type":"4"}},{"id":3662492,"issuer":{"id":6928,"kind":"organization","name":"Gossamer Bio, Inc.","symbol":"GOSS"},"owners":[{"id":40823,"kind":"person","name":"Cox Russell J.","position":1,"cik":"0001512984","reported_name":"Cox Russell J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-12T22:40:20.000Z","date":"2019-02-12","kind":"purchase","acquired":true,"shares":7200,"price":16,"value":115200.0,"ownership":{"direct":true},"balance_after":7200,"source":{"system":"sec-edgar","filing":"0001209191-19-009452","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512984/000120919119009452/doc4.xml","form_type":"4"}},{"id":3696306,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":40823,"kind":"person","name":"Cox Russell J.","position":1,"cik":"0001512984","reported_name":"Cox Russell J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2019-01-15T02:50:04.000Z","date":"2019-01-11","kind":"grant","acquired":true,"shares":1854376,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Vital Therapies, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to the reporting person continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan), twenty five percent (25%) of the RSUs vest annually after the vesting commencement date of January 11, 2019. One hundred percent (100%) of the unvested portion of the RSUs, if any, shall vest in the event of a Termination without Cause or Resignation for Good Reason (each as defined in the reporting person's Change of Control and Severance Agreement)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to the reporting person continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan), twenty five percent (25%) of the RSUs vest annually after the vesting commencement date of January 11, 2019. One hundred percent (100%) of the unvested portion of the RSUs, if any, shall vest in the event of a Termination without Cause or Resignation for Good Reason (each as defined in the reporting person's Change of Control and Severance Agreement)."}],"balance_after":1854376,"derivative":{"underlying":"Common Stock","underlying_shares":1854376},"source":{"system":"sec-edgar","filing":"0001280776-19-000018","document":"wf-form4_154752058722280.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000128077619000018/wf-form4_154752058722280.xml","form_type":"4"}},{"id":3696305,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":40823,"kind":"person","name":"Cox Russell J.","position":1,"cik":"0001512984","reported_name":"Cox Russell J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-01-15T02:50:04.000Z","date":"2019-01-11","kind":"disposition_to_issuer","acquired":false,"shares":1588832,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was cancelled by mutual agreement of the reporting person and Vital Therapies, Inc. The reporting person received a restricted stock unit award as reported in this Form 4 as consideration for this cancellation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty five (25%) of the shares of common stock subject to the option vested on January 3, 2019, and thereafter, one forty-eighth (1/48th) of the shares of common stock subject to the option shall vest monthly, such that all of the shares of common stock subject to the option are vested by January 3, 2022, subject to the reporting person's continuing to be a Service Provider (as defined in the Amended & Restated 2017 Inducement Equity Incentive Plan (the \"Plan)) through each vesting date; provided, that, the unvested portion of the option, if any, that would vest during the 12-month period following his termination date had he remained employed by the Issuer through such date shall vest in the event of a termination without cause following a Change in Control (as defined in the Plan)."}],"balance_after":0,"derivative":{"exercise_price":6.3,"expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":1588832},"source":{"system":"sec-edgar","filing":"0001280776-19-000018","document":"wf-form4_154752058722280.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000128077619000018/wf-form4_154752058722280.xml","form_type":"4"}},{"id":3899568,"issuer":{"id":2649,"kind":"organization","name":"Spyre Therapeutics, Inc.","symbol":"SYRE"},"owners":[{"id":40823,"kind":"person","name":"Cox Russell J.","position":1,"cik":"0001512984","reported_name":"Cox Russell J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2018-06-08T22:43:08.000Z","date":"2018-06-07","kind":"grant","acquired":true,"shares":18400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 12 equal monthly installments beginning on July 7, 2018 until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date."}],"balance_after":18400,"derivative":{"exercise_price":10.28,"expiration_date":"2028-06-06","underlying":"Common Stock","underlying_shares":18400},"source":{"system":"sec-edgar","filing":"0001140361-18-027927","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512984/000114036118027927/doc1.xml","form_type":"4"}},{"id":4107216,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":40823,"kind":"person","name":"Cox Russell J.","position":1,"cik":"0001512984","reported_name":"Cox Russell J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Non-Qualifed Stock Option (right to buy)","published_at":"2018-01-05T02:04:14.000Z","date":"2018-01-03","kind":"grant","acquired":true,"shares":1588832,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty five (25%) of the shares of common stock subject to the option shall vest one year from January 3, 2018, and thereafter, one forty-eighth (1/48th) of the shares of common stock subject to the option shall vest monthly, such that all of the shares of common stock subject to the option are vested by January 3, 2022, subject to the reporting person's continuing to be a Service Provider (as defined in the Amended & Restated 2017 Inducement Equity Incentive Plan (the \"Plan)) through each vesting date; provided, that, the unvested portion of the option, if any, that would vest during the 12-month period following his termination date had he remained employed by the Issuer through such date shall vest in the event of a termination without cause following a Change in Control (as defined in the Plan)."}],"balance_after":1588832,"derivative":{"exercise_price":6.3,"expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":1588832},"source":{"system":"sec-edgar","filing":"0001280776-18-000004","document":"wf-form4_151511784041634.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000128077618000004/wf-form4_151511784041634.xml","form_type":"4"}},{"id":4133145,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":40823,"kind":"person","name":"Cox Russell J.","position":1,"cik":"0001512984","reported_name":"Cox Russell J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & COO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2017-12-13T22:53:49.000Z","date":"2017-12-11","kind":"exercise","acquired":false,"shares":1691,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This incentive stock option is part of an option award granted on March 5, 2013.  The ordinary shares subject to the option award vested over 4 years from the grant date with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter and were fully vested as of March 5, 2017."}],"balance_after":0,"derivative":{"exercise_price":59.13,"expiration_date":"2023-03-04","underlying":"Ordinary Shares","underlying_shares":1691},"source":{"system":"sec-edgar","filing":"0001628280-17-012316","document":"wf-form4_151320561424812.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000162828017012316/wf-form4_151320561424812.xml","form_type":"4"}},{"id":4133144,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":40823,"kind":"person","name":"Cox Russell J.","position":1,"cik":"0001512984","reported_name":"Cox Russell J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & COO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2017-12-13T22:53:49.000Z","date":"2017-12-11","kind":"exercise","acquired":false,"shares":4867,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This incentive stock option is part of an option award granted on August 9, 2012. The ordinary shares subject to the option award vested over 4 years from the grant date with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter and were fully vested as of August 9, 2016."}],"balance_after":0,"derivative":{"exercise_price":46.83,"expiration_date":"2022-08-08","underlying":"Ordinary Shares","underlying_shares":4867},"source":{"system":"sec-edgar","filing":"0001628280-17-012316","document":"wf-form4_151320561424812.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000162828017012316/wf-form4_151320561424812.xml","form_type":"4"}},{"id":4133143,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":40823,"kind":"person","name":"Cox Russell J.","position":1,"cik":"0001512984","reported_name":"Cox Russell J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & COO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2017-12-13T22:53:49.000Z","date":"2017-12-11","kind":"exercise","acquired":false,"shares":44200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This incentive stock option is part of an option award granted on August 25, 2010. The ordinary shares subject to the option award vested over 4 years from the vesting commencement date of July 21, 2010, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments thereafter and were fully vested as of July 21, 2014."}],"balance_after":0,"derivative":{"exercise_price":8.23,"expiration_date":"2020-08-24","underlying":"Ordinary Shares","underlying_shares":44200},"source":{"system":"sec-edgar","filing":"0001628280-17-012316","document":"wf-form4_151320561424812.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000162828017012316/wf-form4_151320561424812.xml","form_type":"4"}},{"id":4133142,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":40823,"kind":"person","name":"Cox Russell J.","position":1,"cik":"0001512984","reported_name":"Cox Russell J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & COO"}}],"security":"Ordinary Shares","published_at":"2017-12-13T22:53:49.000Z","date":"2017-12-11","kind":"exercise","acquired":true,"shares":1691,"price":59.13,"value":99988.83,"ownership":{"direct":true},"balance_after":102821,"source":{"system":"sec-edgar","filing":"0001628280-17-012316","document":"wf-form4_151320561424812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000162828017012316/wf-form4_151320561424812.xml","form_type":"4"}},{"id":4133141,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":40823,"kind":"person","name":"Cox Russell J.","position":1,"cik":"0001512984","reported_name":"Cox Russell J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & COO"}}],"security":"Ordinary Shares","published_at":"2017-12-13T22:53:49.000Z","date":"2017-12-11","kind":"exercise","acquired":true,"shares":4867,"price":46.83,"value":227921.61,"ownership":{"direct":true},"balance_after":101130,"source":{"system":"sec-edgar","filing":"0001628280-17-012316","document":"wf-form4_151320561424812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000162828017012316/wf-form4_151320561424812.xml","form_type":"4"}},{"id":4133140,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":40823,"kind":"person","name":"Cox Russell J.","position":1,"cik":"0001512984","reported_name":"Cox Russell J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & COO"}}],"security":"Ordinary Shares","published_at":"2017-12-13T22:53:49.000Z","date":"2017-12-11","kind":"exercise","acquired":true,"shares":44200,"price":8.23,"value":363766.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 78 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 30, 2017."}],"balance_after":96263,"source":{"system":"sec-edgar","filing":"0001628280-17-012316","document":"wf-form4_151320561424812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000162828017012316/wf-form4_151320561424812.xml","form_type":"4"}},{"id":4141495,"issuer":{"id":2649,"kind":"organization","name":"Spyre Therapeutics, Inc.","symbol":"SYRE"},"owners":[{"id":40823,"kind":"person","name":"Cox Russell J.","position":1,"cik":"0001512984","reported_name":"Cox Russell J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2017-12-06T02:00:26.000Z","date":"2017-12-01","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 12 equal monthly installments beginning on January 1, 2018 until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date."}],"balance_after":30000,"derivative":{"exercise_price":4.73,"expiration_date":"2027-11-30","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001140361-17-045121","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512984/000114036117045121/doc1.xml","form_type":"4"}},{"id":4238709,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":40823,"kind":"person","name":"Cox Russell J.","position":1,"cik":"0001512984","reported_name":"Cox Russell J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & COO"}}],"security":"Ordinary Shares","published_at":"2017-08-09T21:03:56.000Z","date":"2017-08-07","kind":"tax_withholding","acquired":false,"shares":978,"price":155.56,"value":152137.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 168 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 31, 2017."}],"balance_after":51985,"source":{"system":"sec-edgar","filing":"0001512984-17-000005","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000151298417000005/edgardoc.xml","form_type":"4"}},{"id":4394566,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":40823,"kind":"person","name":"Cox Russell J.","position":1,"cik":"0001512984","reported_name":"Cox Russell J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & COO"}}],"security":"Ordinary Shares","published_at":"2017-03-08T22:32:04.000Z","date":"2017-03-06","kind":"tax_withholding","acquired":false,"shares":1793,"price":132.81,"value":238128.33,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":52795,"source":{"system":"sec-edgar","filing":"0001232524-17-000067","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252417000067/edgardoc.xml","form_type":"4"}},{"id":4400055,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":40823,"kind":"person","name":"Cox Russell J.","position":1,"cik":"0001512984","reported_name":"Cox Russell J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & COO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-03-06T23:44:54.000Z","date":"2017-03-02","kind":"grant","acquired":true,"shares":24266,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, March 2, 2017, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":24266,"derivative":{"exercise_price":136.18,"expiration_date":"2027-03-01","underlying":"Ordinary Shares","underlying_shares":24266},"source":{"system":"sec-edgar","filing":"0001232524-17-000057","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252417000057/edgardoc.xml","form_type":"4"}},{"id":4400054,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":40823,"kind":"person","name":"Cox Russell J.","position":1,"cik":"0001512984","reported_name":"Cox Russell J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & COO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2017-03-06T23:44:54.000Z","date":"2017-03-02","kind":"grant","acquired":true,"shares":734,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, March 2, 2017, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":734,"derivative":{"exercise_price":136.18,"expiration_date":"2027-03-01","underlying":"Ordinary Shares","underlying_shares":734},"source":{"system":"sec-edgar","filing":"0001232524-17-000057","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252417000057/edgardoc.xml","form_type":"4"}},{"id":4400053,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":40823,"kind":"person","name":"Cox Russell J.","position":1,"cik":"0001512984","reported_name":"Cox Russell J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & COO"}}],"security":"Ordinary Shares","published_at":"2017-03-06T23:44:54.000Z","date":"2017-03-02","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2017, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."}],"balance_after":54588,"source":{"system":"sec-edgar","filing":"0001232524-17-000057","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252417000057/edgardoc.xml","form_type":"4"}},{"id":4413619,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":40823,"kind":"person","name":"Cox Russell J.","position":1,"cik":"0001512984","reported_name":"Cox Russell J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & COO"}}],"security":"Ordinary Shares","published_at":"2017-03-01T22:01:26.000Z","date":"2017-02-27","kind":"tax_withholding","acquired":false,"shares":2507,"price":136.97,"value":343383.79,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":44588,"source":{"system":"sec-edgar","filing":"0001512984-17-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000151298417000002/edgardoc.xml","form_type":"4"}},{"id":4486341,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":40823,"kind":"person","name":"Cox Russell J.","position":1,"cik":"0001512984","reported_name":"Cox Russell J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & COO"}}],"security":"Ordinary Shares","published_at":"2017-01-19T23:29:03.000Z","date":"2017-01-18","kind":"sale","acquired":false,"shares":3000,"price":130,"value":390000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":47095,"source":{"system":"sec-edgar","filing":"0001232524-17-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252417000004/edgardoc.xml","form_type":"4"}},{"id":4486340,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":40823,"kind":"person","name":"Cox Russell J.","position":1,"cik":"0001512984","reported_name":"Cox Russell J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & COO"}}],"security":"Ordinary Shares","published_at":"2017-01-19T23:29:03.000Z","date":"2017-01-18","kind":"sale","acquired":false,"shares":1000,"price":125,"value":125000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 57 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 30, 2016."}],"balance_after":50095,"source":{"system":"sec-edgar","filing":"0001232524-17-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252417000004/edgardoc.xml","form_type":"4"}}]}